In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 24th, 2009 | 37 | No |
None
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 6.63 | 12.3 | -53.58 | 1 | 7 | -1 | 104 | 509.667 | 16 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
PUBCHEM_PATENT_ID | US5100889; US5153327 | IBM Patent Data |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
TA2R-1-E | Thromboxane A2 Receptor (cluster #1 Of 2), Eukaryotic | Eukaryotes | 6 | 0.31 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
TA2R_HUMAN | P21731 | Thromboxane A2 Receptor, Human | 5.8 | 0.31 | Binding ≤ 1μM |
TA2R_HUMAN | P21731 | Thromboxane A2 Receptor, Human | 5.8 | 0.31 | Binding ≤ 10μM |
Description | Species |
---|---|
G alpha (12/13) signalling events | |
G alpha (q) signalling events | |
Prostanoid ligand receptors | |
Thromboxane signalling through TP receptor |